Advanced Micro Devices, Inc. posts record Q3 2025 results, surges in AI and data center markets, and eyes major growth ahead.

First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in ...

Dyne Therapeutics intends to submit a biologics licence application to the FDA for accelerated approval in Q2 2026.

As the world faces a surge of new synthetic chemicals and increasingly complex toxicity patterns, traditional animal testing ...

AIoT World's Carl Ford speaks with Novelis' Chirag Agrawal about AIoT and Agrawal's views on how AI is impacting Industry 4.0 ...

As 2025 winds down, companies and supply chain leaders are navigating a holiday season and business landscape that are ...

By now virtually every CISO has heard some version of the pitch: “One day, quantum computers will break your encryption, ...

Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health ...

In 2025, the stakes changed. CISOs were hauled into courtrooms. Boards confronted a wave of shareholder lawsuits. And the ...

One of my entries said, “If my dad explains mortgages again, I’m throwing myself into the sun.” The hosts treated it like an actual warning sign, calling it “a serious cry for help” and worrying about ...

Wave Life Sciences' $3.5B valuation reflects both pipeline risk and opportunity. Click here to find out why WVE stock is a ...

The Department of Health and Human Services has set up a plan for AI implementation across the agency that relies on five ...